Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen [Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 3 study evaluating a subcutaneous immunotherapy treatment for grass pollen–induced seasonal allergic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED